Showing 851-860 of 1499 results for "".
- ellacor from Cytrellis Cleared for Moderate-to-Severe Facial Wrinkleshttps://modernaesthetics.com/news/ellacor-from-cytrellis-cleared-for-moderate-to-severe-facial-wrinkles/2473129/FDA has cleared the ellacor system from Cytrellis for the treatment of moderate-to-severe wrinkles in the mid to lower face. The minimally invasive device, featuring Micro-Coring technology, is a first-in-category device that safely removes micro-sized portions of excess
- Allergan Aesthetics, Girls Inc. Continue to Empower Girls Interested in STEMhttps://modernaesthetics.com/news/allergan-aesthetics-girls-inc-continue-to-empower-girls-interested-in-stem/2473126/Allergan Aesthetics is starting its third consecutive year of partnership with Girls Inc. and debuting Empowering Confidence Workshops, a nationwide mentoring initiative. Based on a 2020 Girls Inc. report, many girls have a hard time picturing themselves in science, technology, eng
- Merz Aesthetics Rolls Out New Online Medical Education Forumhttps://modernaesthetics.com/news/merz-aesthetics-rolls-out-new-medical-education-forum/2473114/Merz Aesthetics is launching Merz Aesthetics Medical Forum, an online medical aesthetics education platform for health care professionals around the world. Established by Merz Aesthetics Global Medical Affairs, the Medical Forum provides on-demand content focused on medical aesthe
- Sofwave Medical Goes Public on the Tel Aviv Stock Exchange, Raises $50Mhttps://modernaesthetics.com/news/sofwave-medical-goes-public-on-the-tel-aviv-stock-exchange-raises-50m/2473109/Sofwave Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE) and raised $50 million at a pre-money valuation of ~$200 million. The IPO was led by Barak Capital Underwriters. The company has developed Synchronous Ul
- National Emsculpt Week is Cominghttps://modernaesthetics.com/news/national-emsculpt-week-is-coming/2473104/BTL Aesthetics is bringing back National Emsculpt Week. This holiday was added to the official National Day
- Cynosure Introduces New Fusion Tip for Potenza RF Microneedling System for Enhanced Topical Penetrationhttps://modernaesthetics.com/news/cynosure-introduces-new-fusion-tip-for-potenza-rf-microneedling-system-for-enhanced-topical-penetration/2473094/Cynosure launched a one-of-a-kind Fusion Tip, the newest addition to its Potenza radiofrequency (RF) microneedling system. With its dual-air chamber design, the Fusion Tip captures and releases air towards the skin with each pulse, enhancing the penetration of topicals into the skin by 67 p
- SuperVision180 Launches with New Approach to Aesthetic Educationhttps://modernaesthetics.com/news/supervision180-launches-with-new-approach-to-aesthetic-education/2473089/Offering courses in more than a dozen aesthetic topics with more on the way, SuperVision180 is now offering education and CME credits in the medical aesthetics space. The platform features live procedural webinars, online courses, and hands-on classes. “This is not Zoom,&rdq
- Sonrei Expands Offerings with Three New Sunscreenshttps://modernaesthetics.com/news/sonrei-expands-offerings-with-three-new-sunscreens/2473088/Sonrei has expanded its product line with three new offerings: Sonrei Clearly Zinq Tinted Mineral Gel Sunscreen SPF 45,
- Phase 3 Data: Endo’s Qwo Smooths Cellulite on the Buttockshttps://modernaesthetics.com/news/phase-3-data-endos-qwo-smooths-cellulite-on-the-buttocks/2473083/Endo’s Qwo provides a clinically meaningful improvement in the appearance of moderate to severe cellulite in the buttocks of adult women, when compared to placebo, according to Phase 3 data. "The data, from the largest cellulite studies ever conducted, provides further eviden
- It's A Deal: Eirion Therapeutics, Shanghai Haohai Biological Technology Close $40M Series A Investment and Licensing Dealhttps://modernaesthetics.com/news/its-a-deal-eirion-therapeutics-inc-shanghai-haohai-biological-technology-closes-40m-series-a-investment-and-licensing-deal/2473070/Eirion Therapeutics, Inc. closed a $40 million Series A investment and licensing deal with Shanghai Haohai Biological Technology Ltd. The deal will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eir